Europe

Progentior Labs voted Best Emerging Biotech

Wednesday, October 12, 2011 11:13 AM

Progenitor Labs, the biotechnology company spun out of Plasticell in 2011, is pleased to announce it has been voted Best Emerging Biotech at the Oxford Biotechnology Network’s Annual Awards Dinner held at Pembroke College, Oxford. Progenitor was selected from the biotechnology companies clustered within the “Golden Triangle” comprising London, Oxford and Cambridge.

More... »

Quintiles opens European headquarters in UK

Wednesday, October 12, 2011 10:42 AM

Quintiles has officially opened its new European headquarters in Reading, United Kingdom, bringing together employees from each of its four disciplines.

More... »

Exonhit, Pfizer collaborate in Alzheimer’s research

Tuesday, October 11, 2011 02:26 PM

Exonhit has entered into a research agreement with Pfizer for the identification of new Alzheimer's disease biomarkers using Exonhit's Genome-Wide SpliceArray (GWSA) platform.

More... »

Hybrigenics, Servier ink license and research agreement

Tuesday, October 11, 2011 11:38 AM

Hybrigenics and Servier have signed a license and research collaboration agreement in the field of deubiquitinating enzymes (DUBs) applied to oncology, neurology, psychiatry, rheumatology, ophthalmology, diabetes and cardiovascular diseases.

More... »

Hybrigenics names Munoz to its board of directors

Thursday, October 6, 2011 10:39 AM

Hybrigenics has named Dr. Alain Munoz to its board as a non-executive independent director. Munoz replaces Dr. Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.

More... »

Harries joins Intelsius as CFO

Tuesday, October 4, 2011 12:15 PM

Intelsius has named Alastair Harries chief financial officer. Harries will oversee all finance-related activities including the company's accounting, financial planning and strategic analysis, and will report directly to David Walsh, chief executive officer.

More... »

ProTip receives ESB translational research prize

Friday, September 30, 2011 10:25 AM

ProTip, a company developing medical devices that bring innovative solutions to people suffering from dysfunctions of the larynx, was awarded the ESB Translational Research prize of the European Society for Biomaterials at the ESB annual congress in Dublin, Ireland. This prize, sponsored by the Swiss Society for Biomaterials, is designed to “support scientific efforts in translational research, i.e. scientific activities helping to transform a research idea into a product.”
 
This prize has been awarded for a research program launched by ProTip in 2010, aimed at developing a trachea implant made from a biodegradable microporous polymer and macroporous titanium.
 
“This reward proves that, with high enough focus on relevant and the right research activities, a young firm like ProTip can play an important role in a market as demanding and competitive as that of biomaterials,” said the chairman of ProTip, Maurice Bérenger.

More... »

UK’s DNR to build clinical trials database for diabetes

Wednesday, September 28, 2011 12:31 PM

A new campaign launched by the UK’s Diabetes Research Network (DRN) aims to recruit up to 25,000 diabetes patients over an 18-month period to a ‘consent for approach’ database that should help to accelerate set-up times for clinical trials in the field, according to PharmaTimes.

More... »

InnoCore names Hendriks CEO

Tuesday, September 27, 2011 12:46 PM

InnoCore Pharmaceuticals has named Jan Hendriks chief executive officer. He will take over this position from co-founder Theo Flipsen who will continue his involvement in InnoCore Pharmaceuticals as president of the company.

More... »

Beazeley joins Premier Research Group

Tuesday, September 27, 2011 12:27 PM

Premier Research Group has named Tilly Beazeley senior director, business development covering the United Kingdom and Scandinavia. In this role, Beazeley will be responsible for all of the company’s business development activities in support of strategic growth and development plans for this region.

More... »